O1030 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS]
Ausschreibungsinformationen
TED EULisboa, Portugal
- Art
- 29
- Verfahren
- restricted
- Referenznummer
- 377817-2026
- Geschätzter Wert
- 673,310 EUR
- CPV
- 33600000
OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS]
Lisboa, Portugal
OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS]